Created at	Source	Raw Value	Validated value
Dec. 16, 2022, 4 p.m.	usa	Immunogenicity endpoint 1: IgG total antibody concentration (ELISA);Immunogenicity endpoint 2: Neutralizing antibody titer against SARS-CoV-2 Omicron variants (live virus neutralization test);Safety endpoint: Incidence and severity of Solicited Adverse Events	Immunogenicity endpoint 1: IgG total antibody concentration (ELISA);Immunogenicity endpoint 2: Neutralizing antibody titer against SARS-CoV-2 Omicron variants (live virus neutralization test);Safety endpoint: Incidence and severity of Solicited Adverse Events